Valuation: Iqvia Holdings Inc.

Capitalization 31.19B 27.08B 24.83B 23.38B 43.47B 2,961B 44.27B 295B 115B 1,436B 117B 115B 5,000B P/E ratio 2026 *
22.7x
P/E ratio 2027 * 18.8x
Enterprise value 44.85B 38.94B 35.71B 33.63B 62.51B 4,258B 63.67B 424B 165B 2,065B 168B 165B 7,190B EV / Sales 2026 *
2.59x
EV / Sales 2027 * 2.41x
Free-Float
63.6%
Yield 2026 *
-
Yield 2027 * -
1 day-1.84%
1 week+1.30%
Current month+0.68%
1 month+13.99%
3 months+3.13%
6 months-18.44%
Current year-18.61%
1 week 174.1
Extreme 174.1
188.92
1 month 161.75
Extreme 161.75
188.92
Current year 154.5
Extreme 154.5
247.04
1 year 147.62
Extreme 147.62
247.04
3 years 134.64
Extreme 134.645
261.73
5 years 134.64
Extreme 134.645
285.61
10 years 61.21
Extreme 61.21
285.61
Manager TitleAgeSince
Chief Executive Officer 64 02/10/2016
Director of Finance/CFO 51 27/02/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 04/02/2015
Chairman 64 02/10/2016
Director/Board Member 69 02/10/2016
Date Insider Type Main position Quantity % Market Cap.
05-06Free

Director

228 0.0001%
05-06Free

Director

214 0.0001%
05-06Free

Director

171 0.0001%
Change 5d. change 1-year change 3-years change Capi.($)
-1.84%+1.30%+24.04%-8.90% 31.19B
-1.18%-3.31%-13.59%-17.25% 43.52B
-4.15%-3.49%+269.56%+483.61% 33.1B
-3.51%-7.05%+4.58%+18.80% 31.12B
-2.89%-5.28%+16.62%+13.27% 25.35B
-3.83%-11.38% - - 13.59B
-0.97%+1.37%+45.25%+114.21% 13.1B
-0.18%+5.12%+12.98%+5.39% 13.28B
-0.87%-3.69%+112.13%+78.40% 12.42B
-9.79%-17.09%+20.56%+3,276.12% 10.98B
Average -2.92%-1.97%+54.68%+440.41% 22.76B
Weighted average by Cap. -2.70%-1.69%+56.19%+254.20%

Financials

2026 *2027 *
Net sales 17.29B 15.01B 13.76B 12.96B 24.09B 1,641B 24.54B 163B 63.6B 796B 64.9B 63.49B 2,771B 18.28B 15.87B 14.55B 13.7B 25.47B 1,735B 25.95B 173B 67.25B 842B 68.63B 67.13B 2,930B
Net income 1.39B 1.2B 1.1B 1.04B 1.93B 132B 1.97B 13.11B 5.1B 63.87B 5.21B 5.1B 222B 1.63B 1.41B 1.29B 1.22B 2.27B 154B 2.31B 15.37B 5.98B 74.87B 6.11B 5.97B 261B
Net Debt 13.66B 11.86B 10.88B 10.24B 19.04B 1,297B 19.39B 129B 50.27B 629B 51.3B 50.18B 2,190B 12.84B 11.15B 10.22B 9.62B 17.89B 1,219B 18.22B 121B 47.24B 591B 48.2B 47.16B 2,058B
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (40.6%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.9%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.5%), Europe and Africa (31.8%) and Asia/Pacific (20.7%).
Employees
93,000
Date Price Change Volume
05/06/26 183.45 $ -1.84% 1,265,254
04/06/26 186.88 $ +2.65% 1,676,405
03/06/26 182.05 $ +0.78% 1,561,464
02/06/26 180.64 $ -3.31% 1,679,541
01/06/26 186.82 $ +2.53% 1,404,816
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
183.45USD
Average target price
227.10USD
Spread / Average Target
+23.79%

Quarterly revenue - Rate of surprise